Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers
Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System. (Credit: PRNewswire/Smith & Nephew plc)
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces its PICO Single Use Negative Pressure Wound Therapy Systems have received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of the PICO Single Use Negative Pressure Wound Therapy Systems by hospital experts who serve on one of Vizient’s member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the healthcare industry.
Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.
The PICO sNPWT System provides a portable, easy to use, canister-free design and is equipped with the comfort and mobility of Smith+Nephew soft port technology. This proprietary, silicone-based, four-layer technology uniquely manages wound fluid by simultaneously evaporating and locking it away, keeping excess moisture away from the wound and periwound area.1
This technology also offers expansion of NPWT benefits beyond the wound site by providing compression to the periwound area, which may help improve perfusion.2
The PICO System received this award after being cleared by the Food and Drug Administration (FDA) as the first sNPWT system indicated to aid in reducing the incidence of superficial and deep incisional surgical site infections (SSIs) for high-risk patients in Class I and Class II wounds, post-operative Seroma, and Dehiscence.
“We are thrilled that our PICO System has been recognized by healthcare experts in receiving this distinguished Innovative Technology contract in the US. Surgical site complications continue to be costly events that plague our patients and healthcare systems. “Our PICO technology has been shown to reduce the risk of SSIs across multiple specialties, improving patient care and helping get them home sooner” said Laura Ackerman, Vice President and General Manager, NPWT at Smith+Nephew. “We are committed to innovating the standard of care for patients, and this recognition of the PICO System by Vizient further validates that commitment.”
Source: Company Press Release